DYNC1H1 mutations have been implicated in nervous system diseases (Hoang et al., 2017) and pancreatic cancer (Furukawa et al., 2011), and these mutations are consistent with a high immune activity of tumor mutation load in various cancer types (Bai et al., 2020). Here, DYNC1H1 is linked to cancer.